AstraZeneca shareholder urges board back into talks with Pfizer

LONDON, May 20 (Reuters) - AstraZeneca's twelfth largest shareholder Schroders has joined a chorus of investor disapproval over its rejection of a takeover offer by Pfizer and urged it back into talks.